Preferred Label : purinergic P2Y12 receptor antagonists;

UMLS semantic type : T121 - Pharmacologic Substance;

Is substance : O;

Details


Main resources

You can consult :


https://www.revmed.ch/RMS/2016/RMS-N-520/Double-antiagregation-plaquettaire-pour-le-traitement-et-la-prevention-secondaire-de-la-maladie-coronarienne-Indications-modalites-et-durees-de-traitement
2017
false
false
false
Switzerland
French
journal article
secondary prevention
platelet aggregation inhibitors
coronary disease
coronary disease
Duration of treatment (qualifier value)
hemorrhage
platelet aggregation inhibitors
review of literature
drug therapy, combination
aspirin
administration, oral
treatment outcome
Prasugrel Hydrochloride
ischemia
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
purinergic P2Y12 receptor antagonists
purinergic P2Y12 receptor antagonists
percutaneous coronary intervention
acute coronary syndrome
practice guidelines as topic
ticlopidine
ticlopidine
adenosine
adenosine
Clopidogrel
Ticagrelor

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.